Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple M trial of mifepristone plus misoprostol versus misoprostol alone for early pregnancy failure
NL-OMON48955Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Pregnancy loss comparing Mifepristone + misoprostol with Placebo + misoprostol (2 arms). Primary endpoint: Complete uterine evacuation. Started Jun 2018; status: completed.
02
Drugs
mifepristonemisoprostol
03
Conditions
Pregnancy loss
Beyond the preview
Go deeper on NL-OMON48955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48955.